Nayan Lamba, MD(@NayanLamba) 's Twitter Profileg
Nayan Lamba, MD

@NayanLamba

Resident @Harvard_RadOncđŸ‘©đŸ»â€âš•ïžvia @HarvardMed đŸ©ș and @Columbia 💙| Interests in brain tumors, genomics, and clinical trials 🧠 | Views my own

ID:1326328260591046657

calendar_today11-11-2020 00:58:00

66 Tweets

293 Followers

237 Following

Nayan Lamba, MD(@NayanLamba) 's Twitter Profile Photo

Interested in radiation oncology? Join Harvard Radiation Oncology Residency Program for a virtual open house on 9/28 and 10/11 to learn more about this incredible field and what our program has to offer!! â˜ș

Interested in radiation oncology? Join @HarvardRadOnc for a virtual open house on 9/28 and 10/11 to learn more about this incredible field and what our program has to offer!! â˜ș
account_circle
Shannon M MacDonald(@ShannonMacDonMD) 's Twitter Profile Photo

My tweet- to bring attention to the outdated 18th century laws prohibiting us from providing healthcare to patients across state lines. Covid proved telemedicine was possible. Let’s not go backwards to laws created before the 🚘 & ☎. âŹ‡ïž NEJM nejm.org/doi/full/10.10


account_circle
Dana-Farber News(@DanaFarberNews) 's Twitter Profile Photo

Congrats to Eli Van Allen, MD (Eli Van Allen) and Nick Wagle, MD (@Nikhilwagle) who are being recognized by the Foundation for the National Institute of Health (@FNIH_Org) for their groundbreaking work in oncology research: cc Dana-Farber Division of Population Sciences, Count Me In
bit.ly/3eabnoY

Congrats to Eli Van Allen, MD (@VanAllenLab) and Nick Wagle, MD (@Nikhilwagle) who are being recognized by the Foundation for the National Institute of Health (@FNIH_Org) for their groundbreaking work in oncology research: cc @DFCIPopSci, @count_me_in bit.ly/3eabnoY
account_circle
Brigham and Women’s Radiation Oncology(@BrighamRadOnc) 's Twitter Profile Photo

🆕Check out this NCDB analysis by resident Nayan Lamba, MD, Dr Patrick Ott, and Dr Bryan Iorgulescu in JAMA Network Open part of @JAMANetwork describing overall survival with and utilization rates of first-line ICI among patients with metastatic melanoma: ja.ma/3pRn5qS

🆕Check out this NCDB analysis by #HROP resident @NayanLamba, Dr Patrick Ott, and Dr Bryan Iorgulescu in @JAMANetworkOpen part of @JAMANetwork describing overall survival with and utilization rates of first-line ICI among patients with metastatic melanoma: ja.ma/3pRn5qS
account_circle
Nayan Lamba, MD(@NayanLamba) 's Twitter Profile Photo

Excellent viewpoint by ⁊Nelson Moss and ⁊⁊Viviane Tabar⁩ highlighting how the landscape of brain met management is changing and how brain mets should really be thought of as a distinct disease requiring expert multidisciplinary management: jamanetwork.com/journals/jamao


account_circle